Gemina Laboratories Ltd. (GLAB.CN)

CAD 0.58

(-8.0%)

Long Term Debt Summary of Gemina Laboratories Ltd.

  • Gemina Laboratories Ltd.'s latest annual long term debt in 2023 was 205.98 Thousand CAD , up 3.86% from previous year.
  • Gemina Laboratories Ltd.'s latest quarterly long term debt in 2024 Q1 was 185.06 Thousand CAD , down 0.0% from previous quarter.
  • Gemina Laboratories Ltd. reported annual long term debt of 198.32 Thousand CAD in 2022, up 3554.36% from previous year.
  • Gemina Laboratories Ltd. reported annual long term debt of 5427.00 CAD in 2021, down -85.57% from previous year.
  • Gemina Laboratories Ltd. reported quarterly long term debt of 36.44 Thousand CAD for 2024 Q2, down 0.0% from previous quarter.
  • Gemina Laboratories Ltd. reported quarterly long term debt of 246.04 Thousand CAD for 2023 Q2, up 31.62% from previous quarter.

Annual Long Term Debt Chart of Gemina Laboratories Ltd. (2023 - 2020)

Historical Annual Long Term Debt of Gemina Laboratories Ltd. (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 205.98 Thousand CAD 3.86%
2022 198.32 Thousand CAD 3554.36%
2021 5427.00 CAD -85.57%
2020 37.6 Thousand CAD 0.0%

Peer Long Term Debt Comparison of Gemina Laboratories Ltd.

Name Long Term Debt Long Term Debt Difference
Algernon Pharmaceuticals Inc. - CAD -Infinity%
Asep Medical Holdings Inc - CAD -Infinity%
BetterLife Pharma Inc. 245.23 Thousand CAD 16.006%
BioVaxys Technology Corp. - CAD -Infinity%
ChitogenX Inc. 3.27 Million CAD 93.718%
Rapid Dose Therapeutics Corp. 2.12 Million CAD 90.306%
Defence Therapeutics Inc. 7871.00 CAD -2516.974%
Entheon Biomedical Corp. - CAD -Infinity%
Glow Lifetech Corp. - CAD -Infinity%
Lexston Life Sciences Corp. - CAD -Infinity%
Pharmala Biotech Holdings Inc. - CAD -Infinity%
Doseology Sciences Inc. - CAD -Infinity%
MYND Life Sciences Inc. - CAD -Infinity%
Nova Mentis Life Science Corp. - CAD -Infinity%
PharmaTher Holdings Ltd. - CAD -Infinity%
PreveCeutical Medical Inc. - CAD -Infinity%
Telescope Innovations Corp. - CAD -Infinity%